a public good project by the
Synthesis
Company
of California

© 2026

R. H. A. Becker | doi.page

0 works0 citations0 h-index

R. H. A. Becker

Hospital zum Heiligen Geist(DE)

Publications by Year

Research Areas

Diabetes Management and Research, Diabetes Treatment and Management, Pancreatic function and diabetes, Renin-Angiotensin System Studies, Blood Pressure and Hypertension Studies

Most-Cited Works

→ New Insulin Glargine 300 Units·mL−1 Provides a More Even Activity Profile and Prolonged Glycemic Control at Steady State Compared With Insulin Glargine 100 Units·mL−1(2014)405 cited
→ Ramiprilat enhances endothelial autacoid formation by inhibiting breakdown of endothelium-derived bradykinin.(1991)353 cited
→ Time-Action Profile of Inhaled Insulin in Comparison With Subcutaneously Injected Insulin Lispro and Regular Human Insulin(2005)171 cited
→ Clinical Pharmacokinetics and Pharmacodynamics of Insulin Glulisine(2008)159 cited
→ Effects of lixisenatide once daily on gastric emptying in type 2 diabetes — Relationship to postprandial glycemia(2013)147 cited
→ Low within‐ and between‐day variability in exposure to new insulin glargine 300 U/ml(2014)124 cited

→ Long-term ACE Inhibition Doubles Lifespan of Hypertensive Rats(1997)

124 cited

→ Pharmacokinetic and glucodynamic variability: assessment of insulin glargine, NPH insulin and insulin ultralente in healthy volunteers using a euglycaemic clamp technique(2005)121 cited

→ Investigational new insulin glargine 300 U/ml has the same metabolism as insulin glargine 100 U/ml(2014)106 cited

→ Plasma Exposure to Insulin Glargine and Its Metabolites M1 and M2 After Subcutaneous Injection of Therapeutic and Supratherapeutic Doses of Glargine in Subjects With Type 1 Diabetes(2012)104 cited